# FDA Inspection 1271390 - Lancaster General Women and Babies Hospital Blood Bank - May 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/lancaster-general-women-and-babies-hospital-blood-bank/4b8710f3-d2ae-4da5-87f7-3aa90a418b4d
Source feed: FDA_Inspections

> FDA Inspection 1271390 for Lancaster General Women and Babies Hospital Blood Bank on May 21, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271390
- Company Name: Lancaster General Women and Babies Hospital Blood Bank
- Inspection Date: 2025-05-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1271390 - 2025-05-21](https://www.keypedia.com/records/fda_inspections/lancaster-general-women-and-babies-hospital-blood-bank/623953d2-7613-4fec-a2e9-194bdd83b5b4)

Company: https://www.keypedia.com/companies/lancaster-general-women-and-babies-hospital-blood-bank/a7e81d83-919e-4d2a-8b41-f0daabc581d5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d